REQUEST A DEMO
Total
USD $0.00
Search more companies

GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО) (Russia)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: GK Epidbiomed ZAO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО) is based in Russia, with the head office in Moscow. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. It was first established on July 07, 2006. It currently has a total number of 3 (2022) employees. From the latest financial highlights, GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО) reported a net sales revenue drop of 55.51% in 2024. Its’ total assets recorded a growth of 19.75%. In 2024, GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО)’s net profit margin decreased by 198.67%.

Headquarters
Oruzheinyi, 25, Str.1V
Moscow; Moscow; Postal Code: 125047

Contact Details: Purchase the GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО) report to view the information.

Basic Information
Total Employees:
Purchase the GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО) report to view the information.
Registered Capital:
Purchase the GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО) report to view the information.
Financial Auditors:
Purchase the GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО) report to view the information.
Incorporation Date:
July 07, 2006
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
GK Epidbiomed OOO
100%
Immunolek ZAO
100%
En-Pi-Eich Lebz OOO
50%
Company Performance
Financial values in the chart are available after GK Epidbiomed ZAO (ГК Эпидбиомед ЗАО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-55.51%
Total Operating Revenue
-55.51%
Operating Profit
-152.31%
Net Profit/Loss for the Period
0.5%
Total Assets
19.75%
Total Equity
-14.01%
Operating Profit Margin
-120.82%
Net Profit Margin
-198.67%
Return on Equity (ROE)
-1.81%
Debt / Equity
-10.21%
Quick Ratio
0.12%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?